article thumbnail

Patient experience with Social Prescribing Program in Ontario, Canada [Social determinants and vulnerable populations]

Annals of Family Medicine

Context Social Prescribing (SP) is an approach to help individuals address their health and social needs wherein a healthcare practitioner refers patients to non-clinal services in the community. Models of SP vary, and the experience of patients across these models is less known.

Patients 130
article thumbnail

Risk Factors for Coercion in Open Psychiatric Inpatient Wards

Physician's Weekly

Researchers conducted a retrospective study to examine the prevalence and risk factors of coercive measures in open inpatient wards of a Swiss university psychiatric hospital. They analyzed the use of seclusion and restraint from 2017 to 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Improving Patient Communication

CDOCS

png]</p> <p><span style="font-family:ubuntu; font-size:12px">​</span><span style="font-size:14px"><span style="font-family:ubuntu">By putting ourselves in the shoes of our patients, we can easily see the comfort and trust our patients have developed with their general dentists.

article thumbnail

Episode 384: Antiracism in Medicine – Episode 26 – Racial and Gender Health Disparities in Youth Suicide: Part 1

The Clinical Problem Solvers

They are often the first interface for patients experiencing mental health crises, not academic medical centers. There are a growing number of Child Psychiatric Access Programs, including one in Massachusetts, which provide quick access to psychiatric consultation and facilitates referrals for accessing ongoing behavioral health care.

article thumbnail

Could the Road to an AKS Violation Be Paved with Good Intentions? Pfizer Asks SCOTUS

FDA Law Blog

In its petition filed earlier this month, Pfizer challenges HHS’s interpretation of the AKS as “staggeringly overbroad,” contrary to the congressional intent behind the AKS, and a threat to “almost any activity that facilitates patient access to federally funded healthcare.” Borrasi, 639 F.3d 3d 774 (7th Cir. SCOTUS has until Dec.

article thumbnail

District Court Interprets EKRA

FDA Law Blog

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. A) to induce a referral of an individual to a recovery home, clinical treatment facility, or laboratory; or. (B)

article thumbnail

The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation

FDA Law Blog

Department of Health and Human Services (“HHS”), which reported that discounted purchases totaled $38 billion in 2020, a 27% increase compared to 2019. Use of contract pharmacies ballooned after a guidance issued by HRSA in 2010 allowed covered entities to use multiple contract pharmacies to dispense drugs to covered entity patients.